Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
295 studies found for:    "Adenocarcinoma of lung"
Show Display Options
Rank Status Study
21 Recruiting Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Condition: Stage IV Lung Adenocarcinoma
Interventions: Drug: Certolizumab;   Drug: cisplatin;   Drug: pemetrexed
22 Unknown  Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
Conditions: Lung Adenocarcinoma;   Breast Adenocarcinoma;   Pancreatic Ductal Adenocarcinoma
Intervention: Other: their will be no intervention in any of the groups, the study is retrospective
23 Recruiting Tepotinib Phase II Study in Lung Adenocarcinoma Harbouring MET Exon 14 (METex14) Skipping Alterations
Condition: Lung Adenocarcinoma Stage IIIB/IV
Intervention: Drug: tepotinib
24 Completed Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Conditions: Lung Adenocarcinoma;   Brain Metastases
Interventions: Drug: erlotinib;   Drug: pemetrexed;   Drug: cisplatin
25 Active, not recruiting Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung
Condition: KIF5B-RET-Positive Adenocarcinoma of the Lung
Intervention: Drug: Lenvatinib
26 Unknown  Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Intervention:
27 Not yet recruiting Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion
Conditions: Non-small Cell Lung Cancer Stage I;   Lung Adenocarcinoma
Interventions: Procedure: patients undergo cVATS segmentectomy;   Procedure: Patients undergo cVATS lobectomy
28 Not yet recruiting Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
Conditions: Lung Cancer;   Adenocarcinoma of the Lung
Interventions: Drug: Nivolumab;   Biological: GM.CD40L Vaccine
29 Recruiting Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2
Condition: Lung Adenocarcinoma Patients With Postoperative in pN2
Intervention: Radiation: intensity-modulated radiation
30 Not yet recruiting A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Condition: Lung Adenocarcinoma
Intervention:
31 Completed Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Conditions: Non-small-cell Lung Cancer;   Squamous Cell Carcinoma;   Adenocarcinoma of the Lung
Interventions: Drug: AXL1717;   Drug: Docetaxel
32 Active, not recruiting Lung Cancer Mutation Consortium Protocol
Condition: Adenocarcinoma of Lung, Stage IV
Intervention:
33 Completed EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA
Condition: Lung Adenocarcinoma Metastatic
Intervention: Genetic: LC-RT-PCR and NGS
34 Active, not recruiting Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Non-small Cell Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: Hsp90 inhibitor AUY922;   Other: laboratory biomarker analysis;   Procedure: needle biopsy;   Genetic: mutation analysis;   Other: pharmacological study
35 Active, not recruiting A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Adenocarcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Metformin
36 Recruiting Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma
Conditions: Lung Adenocarcinoma, Stage I;   Diagnoses Diseases;   Circulating Tumor Cells;   Treatment
Interventions: Procedure: lobectomy;   Procedure: segmentecomy;   Drug: chemotherapy(pemetrexed+CISPLATIN);   Procedure: Lymphadenectomy;   Other: CanPatrolTM to detect CTCs
37 Completed Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature
Conditions: Pneumonic-type Adenocarcinoma (P-ADC);   Lung Adenocarcinoma With Bronchiolo-alveolar Feature
Intervention: Drug: Gefitinib
38 Recruiting Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy
Condition: Lung Adenocarcinoma
Interventions: Drug: TKI;   Radiation: Thoracic Hypofractionated Radiotherapy;   Drug: Thymosin Alpha 1
39 Recruiting A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer
Condition: Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma
Interventions: Drug: BYL719;   Drug: INC280;   Drug: LDK378;   Drug: MEK162
40 Completed Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
Condition: Lung Cancer
Intervention: Drug: sorafenib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.